-
Signature
-
/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma
-
Issuer symbol
-
ACN
-
Transactions as of
-
14 Jan 2026
-
Net transactions value
-
-$786,871
-
Form type
-
4
-
Filing time
-
15 Jan 2026, 16:10:49 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sharma Manish |
Chief Strategy & Services Ofcr |
C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO |
/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma |
15 Jan 2026 |
0001911109 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$2,213 |
-8 |
-0.08% |
$276.61 |
9,780 |
14 Jan 2026 |
Direct |
F1 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$25,607 |
-91 |
-0.93% |
$281.40 |
9,689 |
14 Jan 2026 |
Direct |
F1 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$84,798 |
-297 |
-3.1% |
$285.51 |
9,392 |
14 Jan 2026 |
Direct |
F1, F2 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$177,256 |
-617 |
-6.6% |
$287.29 |
8,775 |
14 Jan 2026 |
Direct |
F1, F3 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$148,070 |
-513 |
-5.8% |
$288.64 |
8,262 |
14 Jan 2026 |
Direct |
F1, F4 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$336,157 |
-1,161 |
-14% |
$289.54 |
7,101 |
14 Jan 2026 |
Direct |
F1, F5 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$12,769 |
-44 |
-0.62% |
$290.21 |
7,057 |
14 Jan 2026 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: